Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Briacell Therapeutics Corp 235 15th Street Suite 300 WEST VANCOUVER A1 V7T 2X1 CAN

www.briacell.com Employees: 18 P: 604-921-1810 F: 424-245-3719

Description:

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the `BriaVax` vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 24,798
Enterprise Value, $K 23,938
Shares Outstanding, K 44,204
Annual Sales, $ 0 K
Annual Net Income, $ -4,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,210 K
EBIT, $ -33,330 K
EBITDA, $ -33,250 K
60-Month Beta 1.46
% of Insider Shareholders 5.73%
% of Institutional Shareholders 15.42%
Float, K 41,671
% Float 94.27%
Short Volume Ratio 0.70

Growth:

1-Year Return -87.01%
3-Year Return -93.97%
5-Year Return -94.78%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 95.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 12/16/24
Next Earnings Date 12/12/24
Earnings Per Share ttm -1.17
EPS Growth vs. Prev Qtr -214.29%
EPS Growth vs. Prev Year 56.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-300 on 01/02/20

BCTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -191.19%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.47
Book Value/Share -0.15
Interest Coverage -0.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar